Navigation Links
Newer Blood Pressure Drugs Decrease Risk Of Diabetes

Patients taking newer blood pressure drugs have a decreased risk of developing diabetes, according to an analysis of the biggest clinical trial in Europe. The study found that// only 8 percent of the people on newer medicines developed diabetes as against 11.4 percent of those on older drugs.

The study involved 19,000 people. The study compared drugs like Norvasc and Coversyl with a beta-blocker and a diuretic. Norvasc is amlodipine, while Coversyl is perindopril. Professor Peter Sever of Imperial College in London, co-chairman of the study, said the findings underlined the fact that beta-blockers were no longer effecting in treating blood pressure.
RAS
'"/>




Page: 1

Related medicine news :

1. The Efficacy Of Newer Stents Questioned
2. Newer Generation Sleeping Pills Lack Superior Performance
3. Autoimmune Diseases – Newer Preventive Measure
4. Need for Newer AIDS Drugs In China
5. Newer Antidepressants May Trigger Violent Behavior
6. Newer Class of Antidepressants Similar in Effectiveness, Side Effects Differ
7. Study Sheds Light on Value of Newer Antipsychotic Drugs for Schizophrenia
8. Cellulose Nanocrystal Research Paves the Way for Newer Vaccines, Computer Inks
9. Recommendations for Treatment of Blood Pressue
10. Blood Cells Capable of Regenerating Liver
11. Blood clots likely in long travel

Post Your Comments:
(Date:11/30/2009)...and dessert at the holiday table are even less of ...According to a new research report recently appear...ebj.org ), a diet that is high in fat and in sugar...our bodies to store too much fat. This means these... difficult task of converting high-fat and high-su...
(Date:11/30/2009)...J. Rappa, MD, explores the intricate connection be...Healing Heart to Soul: One Doctor’s Journey ...09). , Dallas, TX (Vocus)...o let go of negative emotions, whether caused by u...houlders. Oftentimes, this disease of the human sp...
(Date:11/30/2009)...ov. 30 EMD Serono, an affiliate of...hat it received a refuse to file letter from the U...ug Application (NDA) for Cladribine Tablets, EMD S...on of cladribine, as a therapy for relapsing forms...ill work closely with the FDA to fully understand ...
(Date:11/30/2009)...y help delay progression and reduce expenses, rese...ay News) -- Medical care for osteoarthritis patien...r, according to a new study. , Of that amount, ....1 billion in out-of-pocket costs. Annual insurer ... male patient. Women also have higher out-of-pocke...
(Date:11/30/2009)...ting a tumor without disturbing normal tissue pres...apies can be invasive and harsh. , Researchers a...y they might deliver the right therapy directly to...which specifically bind to living tumor tissue. ,...nt with liver cancer until they found the best mol...
Breaking Medicine News(10 mins):Health News:Western diets turn on fat genes 2Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 2Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 3Health News:Osteoarthritis Costs U.S. Over $185 Billion a Year 2Health News:First live targeting of tumors with RNA-based technology 2Health News:First live targeting of tumors with RNA-based technology 3
...ORTLAND, Ore. New research at Oregon Health & Sci...te suggests vaccines that specifically target HIV ...omes a rapidly replicating, system-wide infection ...icine and will appear in a future printed edition...
...This release is available in French . , Montrea...icts at medically supervised clinics does not pose... a new study by Serge Brochu, a researcher at the ...ation Initiative, didn,t have a negative impact on...
...Past behavior is generally considered to be a good...dicates that may not be the case in the developmen...ls., University of Washington social scientists ... early adolescence. Surprisingly, early signs of ...
...DIANAPOLIS, Feb. 17 The State Commander of the In...t he called a "slap in the face" to supporters of ...y Governor Mitch Daniels. , , "At his (Governor D... and what do we get in return? The same lame, ill-...
...h study of tibolone, also used for osteoporosis bu...increased risk, , , TUESDAY, Feb. 17 (Heal...sed to treat menopausal symptoms and to prevent os...ivors of the disease. , Tibolone isn,t available i...
...sidents at risk for chronic kidney disease urged t...ney disease (CKD), which affects 20 million people....S. and it is growing at a steady and alarming rat...ns or symptoms until the kidneys are about to fail...
Other Medicine News:Health News:OHSU vaccine research targets HIV in the slower, early stage of infection 2Health News:Medical prescription of heroin does not pose neighborhood risk 2Health News:Anti-social behavior in girls predicts adolescent depression seven years later 2Health News:Legion Condemns Governor's Non-Response to ISSCH Proposal As 'Slap In The Face' 2Health News:Menopause Drug Tied to Breast Cancer Recurrence 2Health News:Task Force Alerting Nevadans to 'Silent' Killer Disease Crisis 2
(Date:11/30/2009)...N.J. and CHICAGO, Nov. 30 Today at...f the Radiological Society of North America (RSN...d the enrollment of the first patient in an intern...fficacy and safety of florbetaben (BAY 94-9172) PE... in the brain, which are a pathological hallmark o...
(Date:11/30/2009)...TEL AVIV, Israel, November 30 Opto...III(TM) dual channel microphone, the most advanced...l magnetic resonance imaging,(fMRI) environments. ... major step forward for fiber,optic microphone tec...r, with,low-latency adaptive noise cancelling. The...
(Date:11/30/2009)... INDIANAPOLIS, Nov. 30 T...roved Cymbalta® (duloxetine HCl) for the main...(GAD) in adults, Eli Lilly and Company (NYSE: LL...ety disorder can be a chronic illness, it is impor...ent option that is effective in both the acute and...
Breaking Medicine Technology:Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 1NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 2NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53144 3Roxane Laboratories Inc Announces the Launch of Risperidone Oral Solution 1mg mL 53140 1Roxane Laboratories Inc Announces the Launch of Risperidone Oral Solution 1mg mL 53140 2Osteotech Resumes Shipments of Bulgarian Tissue 13259 1Osteotech Resumes Shipments of Bulgarian Tissue 13259 2Osteotech Resumes Shipments of Bulgarian Tissue 13259 3
...Potential of NeoVista,s Epi...9 NeoVista, Inc. made public,yesterday 18-month d...examining its novel epiretinal brachytherapy for t...generation (AMD) at the 41st Scientific Meeting of...tudy, which was initiated,to test the safety and e...
...icals,Inc. (Nasdaq: IDEV ) today announced that i...zation agreement with Teva Pharmaceutical Industri...oclone. Indevus previously,announced promising dat...d,multi-center Phase II trial in patients with per...duced a statistically significant benefit in,multi...
Other Medicine Technology:NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 2NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 3NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting 4Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 2Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 3Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 4
Hardy Micro Dissector
Hardy Nasal Bivalve Specula
Landolt Hypophysectomie Instrument, Spoon
Hardy Pituitary Spoons
Medicine Products: